Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer
Clinical trial NCT00639925 · UNKNOWN
Trial details
- NCT number
- NCT00639925
- Sponsor
- Fukushima Medical University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2013-03-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.